Guardian Pharmacy Services, Inc. GRDN

Updated: 13 Jun 2026

NYSE | Long-term care pharmacy services

No signal published yet

We already track Guardian Pharmacy Services and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Guardian Pharmacy Services free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Sector
Long-term care pharmacy services
We're already tracking Guardian Pharmacy Services, Inc. — here are the latest events we've registered

Recent News

  • On May 6, 2026, the company reported first-quarter revenue of $336.6 million and updated its full-year financial guidance. In June 2026, the stock reached an all-time high of $43.85 following an amendment to its credit facility that extended maturity to 2030.

What Firelda Watch includes for Guardian Pharmacy Services, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Guardian Pharmacy Services, Inc. will be delivered in the same format.

Want to follow Guardian Pharmacy Services, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Guardian Pharmacy Services free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Guardian Pharmacy Services, Inc. GRDN
Guardian Pharmacy Services — follow and we'll monitor it
Follow Guardian Pharmacy Services free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.